摘要
目的探讨持续静-静脉血滤(CVVH)在治疗危重症中的作用与安全性。方法总结2002年1月至2006年1月对重症监护病房(ICU)采用 CVVH 治疗109例危重患者的临床应用情况。结果 109例患者每次血滤治疗时间为18~72 h,每例治疗总时间1~12 d。并发症有:一过性低血压13例;凝血5例;出血2例;局部或全身感染3例。结论 CVVH 在危重症患者的治疗中有良好的安全性、耐受性、方便性和高效性。高质量的管理是血液滤过治疗获得成功的重要保证。
Objective To evaluate the role and safety of continuous vano-venous hemofiltration(CVVH) in treating critical patients. Methods We summarized 109 cases of critical patients treated by CVVH in our ICU from 2002 to 2006. Results The therapy time ranged from 18 to 72 hours. Of all patients, there were 13 cases of hypotension, 5 cases of filter occlusion,2 cases of bleeding and 3 cases of local or blood infection. Conclusion CVVH can be appli-Gated in critical patients with good safety and efficiency. High-quality management plays an important role in the carry--out of CVVH.
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2006年第S2期182-182,184,共2页
Chinese Journal of Practical Internal Medicine
关键词
持续静-静脉血滤
危重症
Continuous veno-veno hemofiltration
Critical care